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Abstract
Background: Over 40% of children with cancer have reported that chemotherapy-induced nausea and vomiting
(CINV) are the two most distressing side-effects of treatment even when antiemetic drugs have been used.
Objectives: The purpose of this article is to report the findings from a feasibility and pilot study using auricular
point acupressure point for CINV in a small group of children in Taiwan.
Methods: This was a crossover randomized design study. CINV symptoms were assessed on 10 patients just
prior to and for 7 days following each of three rounds of chemotherapy drugs (CTX). They received standard
care (SC) and were not entered into a test treatment group until they completed the baseline assessment, which
was conducted during their first round of chemotherapy after entering the study. Just prior to receiving the
second round of CTX, patients were randomized into one of two treatment conditions: auricular acupressure
intervention, in addition to standard care (AAP) or auricular acupressure using sham auricular points (SAP) in
addition to standard care. For the third round of CTX, they were switched to the other treatment group.
Results: The enrollment rate for this study was 77% of the children invited to participate and of those, 88%
provided completed data sets for all three treatment conditions. Patients in the AAP group reported significantly
lower occurrence and severity of nausea and vomiting than patients in the SC group ( p < 0.05). There were no
significant differences of nausea and vomiting for patients between the AAP and SAP groups. All of the patients
took antiemetic medication on the day they received CTX, and 80% of patients reported that the antiemetics did
not help to treat CINV.
Conclusions: These preliminary findings did show evidence that AAP is acceptable to the children and their
parents to prevent/treat CINV. However, there were no statistically significant differences between the AAP and
SAP groups in the prevention/treatment of CINV. There were clinical trend differences between the groups,
which may due to the small sample size. In a larger study, it would be important to determine whether the
effects of the AAP and SAP treatment are independent of any psychologic effects, such as the researcher’s
increased presence in both treatment groups.
Introduction
Even with recent advances in the understanding ofchemotherapy-induced nausea and vomiting (CINV) and
the use of chemotherapy-specific antiemetic drugs,1–4 over
40%5–7 of children report that nausea and vomiting are two of
the most distressing side-effects that they experience while
receiving treatment with chemotherapy.5–7 The high preva-
lence of these symptoms and level of distress reported by the
children indicate poor control of CINV for children with
cancer. Acupuncture/acupressure has been shown to be ef-
fective for treating/preventing CINV as evidenced at the
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National Institutes of Health (NIH)8 and has been re-
confirmed in other studies.9,10 Acupuncture/acupressure has
been reported to be effective for the control of CINV in the
United States8 and in Germany.11,12
Auricular therapy, along with acupoints in other body
parts, is a well-established treatment strategy in Traditional
Chinese Medicine (TCM). Auricular therapy, as proposed by
Dr. Nogier, a well-known French neurosurgeon, is based on
the understanding that the ear represents a simulation of an
inverted fetus within the womb and therefore provides
acupressure points corresponding to all parts of the human
body, including the internal organs.13,14
In TCM, a disease is viewed as being caused by the im-
balance of a person’s energy, or qi.15 Qi is the basal energy of
the body that flows through the entire body and is the basis
for all movement and action.15 When acupoints are pressed,
the stimulation regulates qi, activates meridians and collat-
erals, balances the yin and yang, and is thus suitable for
treating health problems and restoring health.15
Study Purpose
The aims of this study were to (1) examine the feasibility
of recruiting children with cancer into a future larger study
for the auricular acupressure point (AAP) to prevent/treat
CINV, (2) evaluate the feasibility of performing the research
procedures, and (3) determine whether there is preliminary
evidence to suggest that the experimental AAP treatment is
more effective than the placebo SAP and standard care for
CINV.
Methods
This was a crossover, randomized design feasibility
study. Subjects were entered into the study for three suc-
cessive rounds of chemotherapy. CINV data from the next
round of chemotherapy after being entered into the study
(‘‘study round 1’’) was used as the standard care (SC) group
and provided baseline data. Prior to ‘‘study round 2,’’
subjects were randomized into two treatment conditions:
(1) auricular acupressure intervention, in addition to stan-
dard care (AAP); and (2) auricular acupressure using sham
points in addition to standard care (SAP). For ‘‘study round
3,’’ the groups were crossed over to the other treatment
condition.
Subjects
Patients were eligible for this study if (1) they were be-
tween 5 and 18 years; (2) were diagnosed with cancer and
had at least one round of chemotherapy treatment; (3) were
prescribed chemotherapy drugs (CTX) with high or moder-
ate level emetogenic potential chemotherapy agents;16 (4)
were prescribed standard antiemetics with their CTX; and (5)
had not previously received any acupuncture or acupressure
treatments in the previous 3 months. The number of days in
a round of CTX varied from 1 to 5 days. Each course had a 2-
to 4-week interval. The standard emetics prescribed by the
physicians included 5-hydroxytryptamine 3 (5-HT3) receptor
antagonists such as ondansetron (Zofran), granisetron (Ky-
tril), or a corticosteroid (dexamethasone).
Intervention
During the application of the seeds (usually less than 5
minutes) patients were asked to stay silent, sitting in com-
fortable chairs/bed. The outer ear including the earlobe was
cleaned with 75% alcohol before the small pieces of adhesive
tape with two seeds were taped onto each selected auricular
point. The auricular (outer ear) points selection for the AAP
group were those specific for nausea and vomiting according
to Dr. Huang’s ear reflex theory.13,15 Five (5) reflex points
(shenmen, sympathetic, cardia, stomach, digestive subcortex)
(digestive subcortex was used to treat diseases of digestive
systems, located at the center of the lower half of the interior
antitragus) (p. 196)15 were used in intervention (Fig. 1). The
placebo group received acupressure treatment on the fol-
lowing auricular (outer ear) acupoints (which refer to the
external knee point, vision, shoulder joint, and eye),15 which
are not related to CINV (Fig. 1). The auricular electrical fin-
der was used to locate the acupoints with disorder. The
sounds of the positive reaction from the auricular electrical
finder, the change color, and shape of the acupoints were
used to determine the auricular location. After the acupoints
were found, the therapist confirmed the acupoints of the
corresponding part of the body with the patient. The tapes
with the seeds were carefully placed on the right acupoints.
Then, the auricular therapist demonstrated the pressing
technique to patients and parents before asking them to do a
return demonstration. They were instructed to apply mod-
erate stimulation by pressing slightly to more firmly until
FIG. 1. Auricular acupoints for che-
motherapy-induced nausea and vomit-
ing treatment.
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patients felt either mild discomfort or tingling. Bilateral
auricular (both earlobes) points were used for treatment.
Each patient was asked to press the acupoints by them-
selves at least 3 times a day for at least 3 periods of 3-
minute duration each day, even if they did not have
symptoms. They were also instructed to press the seeds as
soon as they felt nausea, preferably before they were going
to vomit. Seeds were kept on auricular points for 7 days.
Patients and parents were instructed to remove them after
the treatment ended. All of the treatments were conducted
by the same therapist.
Measures
Morrow Assessment of Nausea and Emetics17
Morrow Assessment of Nausea and Emetics, a self-
report questionnaire, was developed in adults used to
measure occurrence (yes or no), duration (how many
hours), and severity (score 1–6) after the beginning of
chemotherapy, as well as the use of antiemetic and the
effects. The duration of nausea and vomiting that was
present could thus be quantified. It was a 17-item ques-
tionnaire with good internal consistency, test–retest reli-
ability, and concurrent validity.17 It was modified and
adapted for use by children. In this study, the score of
severity was recorded as ‘‘slight,’’ ‘‘moderate,’’ and ‘‘se-
vere,’’ and the score of antiemetics effects was recorded as
‘‘did not help’’ and ‘‘provided relief.’’
Demographic information
Demographic and relevant data were collected from medi-
cal records and included age, gender, cancer diagnosis, and
treatment information. Chemotherapeutic agents, and the an-
tiemetics used during data collection were also recorded.
Study booklet
Each child subject and their parent received a booklet in-
cluding information about the acupressure technique (in-
cluding intensity and duration). Patients/parents were asked
to keep a diary of stimulation times (frequency), the number
of acupoints stimulated and stimulation duration at each of
the acupoints, and whether or not the child felt relief from
the symptoms they were experiencing.
Procedures
The study began after receiving approval from the Human
Subjects Review Committee for the study setting. Subjects
were recruited from a large children’s hospital in Taiwan. The
hospital’s established procedures for protecting confidential-
ity were strictly followed. Following the institutional review
board’s guidelines, potential subjects and their parent(s) were
approached by a familiar member of the clinical team to
provide introductory information about the study and de-
termine their willingness to meet with a member of the re-
search team. After consent and assent forms were signed,
baseline data were collected during the next new round of
chemotherapy as the standard care data (SC). Then, patients
were randomized to one of the two groups: AAP or SAP,
using a computer-generated randomization table, as outlined
in the study flow chart in Figure 2. After the completion of the
first intervention, patients were switched to AAP or SAP. The
duration for two interventions ranged from 2 weeks to 1
month, depending on the chemotherapy protocol. For the
first treatment, it took 20–30 minutes to complete the study,
and 5–10 minutes for the follow-up treatment. Patients re-
ceived standard antiemetic medications as prescribed by their
clinical team. For each round, data were collected prior to
chemotherapy administration and then daily for 7 days after
the tapes had been placed onto the earlobes.
FIG. 2. Flow chart of patient
recruitment.
FIG. 3. Occurrence of nau-
sea (A) and vomiting (B) after
chemotherapy was adminis-
tered. SC, standard care;
AAP, auricular acupressure
acupoints; SAP, sham auric-
ular acupoints.
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Statistical Analyses
Descriptive statistics were estimated for the demographic
characteristics of the participants. The intervention effect of
treatments during the seven-time postchemotherapy assess-
ment points were analyzed using the generalized linearmodel18
with the generalized estimated equation for longitudinal cate-
gorical measurements19 (i.e., occurrence, severity, and effects of
medication), and a mixed-effects model20 was used for longi-
tudinal continuous measurements (i.e., duration of nausea and
vomiting). Themodel included fixed effects for group (i.e., AAP,
SAP, and SC) and time. Model effects were tested at a signifi-
cance level of 0.05. The post-hoc test was used to do multiple
comparisons among SC, AAP, and SAP groups. All of the data
analyses were performed using SAS software, version 9.2.21
Results
Demographic findings
Patients (n = 10) who enrolled in the study were all able to
complete the study for baseline assessment and post-
chemotherapy test points. Patients included 6 boys and 4
girls; 4 had been diagnosed within the last 3 months, 2 were
in remission but continuing on-treatment; and 4 had relapsed
and were on-treatment. The mean age of the patients was
13.29 years (range 6–18, standard deviation [SD] = 3.31
years). The mean duration of their illness since diagnosis for
the on-treatment group was 2.36 months (range = 0.60–5.43,
SD= 1.64 months) and for the relapse group was 29.9 months
(range = 24.60–37.40, SD= 5.75). The diagnoses included leu-
kemia (n = 3, 30%) and other solid tumors (n = 7, 70%). The
average number of children including the patients per
household was 3 (range 2–4, SD= 0.94). No patient had ever
used acupressure or acupuncture prior to study enrollment.
None of the patients reported nausea or vomiting during the
day prior to the chemotherapy being administered.
Specific Aims
Aim 1: To examine the feasibility of recruiting
children with cancer into the larger study
Twenty-two (22) patients were approached for their will-
ingness to participate. Five (5) parents refused due to time
constraints. Seventeen (17) patients agreed to participate. Of
the 17 who agreed, 2 patients received bone-marrow trans-
plantation (BMT) and became ineligible. The treatment pro-
tocol was changed for 4 other children during data collection,
and thus they also became ineligible to continue the study.
One (1) patient refused to complete the study because she
thought the intervention was useless and dropped out of the
study. Thus, 10 patients completed the intervention.
Table 1. Post-Hoc Tests of the Occurrence, Severity, and Duration of Nausea and Vomiting
Nausea Vomiting
OR (95% CI) p-Value OR (95% CI) p-Value
Occurrence AAP vs SC 0.30 0.10 0.88 0.0289 0.17 0.05 0.53 0.0024
SAP vs SC 0.44 0.17 1.19 0.1058 0.39 0.18 0.85 0.0172
AAP vs SAP 0.67 0.34 1.34 0.2590 0.44 0.13 1.46 0.1775
Severity AAP vs SC 2.60 1.09 6.21 0.0310 6.73 2.25 20.16 0.0007
SAP vs SC 2.44 0.98 6.05 0.0548 3.02 1.29 7.07 0.0111
AAP vs SAP 1.07 0.54 2.13 0.8500 2.23 0.59 8.39 0.2346
Mean (95% CI) p-Value Mean (95% CI) p-Value
Duration AAP vs SC - 0.92 - 4.51 2.66 0.6193 - 0.40 - 2.52 1.72 0.7154
SAP vs SC 0.14 - 5.22 5.50 0.9588 - 1.01 - 3.48 1.46 0.4338
AAP vs SAP - 1.07 - 4.65 2.52 0.5665 0.61 - 1.51 2.73 0.5804
OR, odds ratio; CI, confidence interval; AAP, auricular acupressure acupoints; SAP, sham auricular acupoints; SC, standard care.
FIG. 4. Duration (A) and severity (B–D) of nausea. SC, standard care; AAP, auricular acupressure acupoints; SAP, sham
auricular acupoints.
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Aim 2: To assess the feasibility of successfully
completing each of the three protocols
During the two intervention trials, the patients were asked
to keep the taped seeds on their ears for 7 days following the
beginning of both rounds of chemotherapy. Thus, the pos-
sible total number of days the 10 children would keep the
seeds on their ear was 140. The possible number was de-
termined by multiplying 10 (children) times 2 (treatment
conditions) times 7 days. During the treatment, 1 patient on
day 2, 1 patient on day 5, and 1 patient on day 6 took off the
tapes due to itching. These patients continued to complete
the study assessment and were included in the final analysis.
For the rest of the patients, the tape on the seeds fell off at
different time points (i.e., from day 1 to day 7), and was
replaced by the therapist as soon as it was noted. Therefore,
the actual total number of days that the tapes were on the
patients’ ears was 123 or 88% of the possible days. This
suggests that the intervention is acceptable to the children
and their families and is therefore feasible.
Aim 3: To analyze the longitudinal CINV data
Change patterns of nausea occurrence, duration, and
severity. The graphic in Figure 3 shows the frequency of
nausea and vomiting in the three groups. Because the actual
day 1 data (the pretest data collection, prior to chemotherapy
being administered, for all three groups) were reported as
‘‘none, or 0’’ for nausea and vomiting, the data for that day
were eliminated and the day 2 data (first day after the che-
motherapy) became day 1 for the purposes of analysis. The
SC group reported more nausea overall than either the AAP
or the SAP group (Fig. 3A). In the SC group, 3 children (30%)
continued to report nausea even on the seventh day after the
chemotherapy had been administered. The SAP group re-
ported the same amount of nausea as the SC group for the
first 2 days after the start of chemotherapy, but declined
steadily after that with only 2 children (20%) still reporting
any nausea on day 6 (Fig. 4). The AAP group reported slightly
less nausea the first day, and the same as the other two groups
on day 2, but declined until day 5, after which they reported
no nausea. While the analysis did not show statistical signif-
icance, this trend seems clinically significant and suggests
that a study with a larger sample should be conducted.
Table 1 presents the results of the post-hoc tests of multiple
comparisons among the three groups across time. It shows
that the patients in the AAP group had 0.3 times fewer oc-
currences of nausea (95% confidence interval [CI] = 0.10, 0.88;
p = 0.0289) than those in the SC group. No statistical differ-
ences were found between the occurrences of nausea in AAP
and SAP groups. This analysis is consistent with and sup-
ports the findings in Figure 3.
Change patterns of vomiting occurrence, duration, and
severity. In Figure 3B, patients in the SC group reported
more overall vomiting than patients either in the AAP or the
SAP group, and patients in the SAP group reported more
vomiting problems than patients in the AAP group. Only
patients in the SC group reported vomiting at day 6 and day
7. Patients in the AAP group had 0.17 times (95% CI = 0.05–
0.53, p= 0.0024) of having vomiting than patients at SAP,
and patients at SAP had 0.39 times (95% CI = 0.18–0.85,
p = 0.0172) of having vomiting than patients in the SC group.
There were no statistically significant differences of vomiting
occurrence between patients in the AAP or SAP group
(OR = 0.44, 95% CI = 0.13–1.46, p = 0.1775).
Except for acute vomiting, patients in SC group had ex-
perienced longer duration of vomiting (Fig. 5A) and higher
severity (Fig. 5D) than patients in the AAP and SAP groups,
but the differences were not statistically significant among
the three groups (Table 2). The vomiting duration for AAP
and SAP had mixed findings; for example, patients in the
FIG. 5. Duration (A) and severity (B–D) of vomiting. SC, standard care; AAP, auricular acupressure acupoints; SAP, sham
auricular acupoints.
Table 2. Post-Hoc Tests of Medication Use
Medication
OR (95% CI) p-Value
Occurrence AAP vs. SC 1.07 0.40 2.85 0.8911
SAP vs. SC 0.81 0.50 1.30 0.3814
AAP vs. SAP 1.32 0.55 3.16 0.5280
Effect AAP vs. SC 0.86 0.25 2.93 0.8085
SAP vs. SC 1.29 0.65 2.59 0.4673
AAP vs. SAP 0.66 0.26 1.67 0.3858
OR, odds ratio; CI, confidence interval; AAP, auricular acupres-
sure points; SAP, sham auricular acupoints; SC, standard care.
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AAP group reported longer duration on the first 2 days, but
a shorter duration from day 3 to day 5 than patients in the
SAP group. Both the AAP group and SAP group had less
severe level of vomiting occurrences, having 6.73 times (95%
CI = 2.25, 20.16, p= 0.0007) and 3.02 times (95% CI = 1.29–7.07,
p = 0.0111) significantly higher odds than the SC group, re-
spectively. Even though the odds of the AAP group is 2.23
times higher than the odds of the SAP group, this is not
significant ( p= 0.2346).
Medication Taken to Prevent Nausea and Vomiting
All of the patients in each of the three groups took med-
ication to treat CINV on day 1 (on the day when CTX were
administered) and gradually decreased the amount taken
during the CTX. In Figure 6A, patients in the AAP group had
a higher rate of using medication to prevent CINV than
patients in the SAP or SC group, but there was no consistent
finding about the medication taken to treat nausea and vo-
miting across time for three groups. Among the three groups
(Fig 6B), about 80% of patients on day 1 and over 40% of
patients on day 2 reported that the antiemetics did not help
to treat CINV. The post-hoc analysis showed no significant
differences among the three groups in either medication use
or effectiveness of medication use (Table 2). The most use of
antiemetics medication was Kytril (granisetron), followed by
Zofran (ondansetron) (Fig. 7).
Aim 4: To determine effect size for use in a future
study of the efficacy of the intervention
In order to estimate the effect size, Crame´r’s uc was used.
A total of 315 patients would be needed for three groups for
a small effect size (Crame´r’s uc= 0.2), 51 patients would be
needed for a medium effect size (Crame´r’s uc = 0.5), and 20
patients would be needed for a large effect size (Crame´r’s
uc = 0.8).
Discussion
This is the first feasibility study to assess auricular acu-
pressure to prevent/treat CINV in children with cancer. The
strength of this study was the inclusion of both an inter-
vention and a placebo group to determine whether the AAP
is effective due to treatment itself but not psychologic effects.
This study has limitations due to small sample size, hetero-
geneous nature of the patients (including age, diagnosis),
and the use of antiemetic regimens prescribed in the study
setting.
In this study, the enrollment rate of the AAP in this study
was 77%. The reasons given for refusal to participate were
due to parental time constraints and patient’s not wanting to
fill out the questionnaire of self-report data, which is often
encountered in survey studies.6, 22 During the AAP treatment,
3 patients complained about itching of the tapes on day 2, day
5, and day 6 and decided to take them off. The tape that was
used for AAP treatment had contained latex (provided by
Auricular Medicine International Research & Training Center,
FL). A latex-free, hypoallergenic, and gentle tape will be used
for further AAP application in the future study in order to
decrease the skin irritation for patients. Overall, 88% patients
during the intervention were able to continue wearing their
tapes until the study was completed. Some parents actively
asked the auricular therapist if they could continue to receive
the treatment after their participation in the study had ended.
Thus, the authors have confidence to conclude that patients
FIG. 6. Medication use (A)
and effects (B, C) to prevent/
treat chemotherapy-induced
nausea and vomiting. SC,
standard care; AAP, auricular
acupressure acupoints; SAP,
sham auricular acupoints.
FIG. 7. (A–C) Medication
used for patients to prevent/
treat chemotherapy-induced
nausea and vomiting. SC,
standard care; AAP, auricular
acupressure acupoints; SAP,
sham auricular acupoints.
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and parents can accept AAP as an addition to the usual care to
prevent/manage CINV.
Conclusions
Due to the small sample size, it is not possible to differ-
entiate the efficacy between AAP intervention and placebo
(SAP) in this study. However, patients in the AAP group did
have a lower occurrence of acute and delayed nausea and
shorter vomiting duration than patients in SAP and SC
groups across time. At the present time, it is not possible to
draw the conclusion that the AAP is more effective than SAP
due to the small sample size. The effects of AAP and SAP for
treating CINV were varied across time. It is not possible to
differentiate the true effects of AAP because of the possible
psychologic effects of more frequent visits by the auricular
therapist. The strength of this study design is the inclusion of
a placebo group. A larger study with more subjects using the
same design as was used here may be able to determine the
effects of AAP in the future.
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